budesonide ER / Generic mfg.  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide ER / Generic mfg.
NCT02800824: Bioequivalence Study of Budesonide Rectal Aerosol Foam and UcerisĀ® Rectal Aerosol Foam

Completed
1
NA
Budesonide, Uceris
Padagis LLC
Healthy
06/16
 
NCT04854538: Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

Completed
1
30
RoW
Ekmasonid, Uceris, Uceris (first dose), Uceris (second dose)
Genuine Research Center, Egypt, Hikma Pharmaceuticals LLC
Healthy
10/20
12/20

Download Options